October 2017

Formulary Considerations: The Past, Present, and Future

October 16, 2017

Evidence-Based Oncology

The hospital formulary system is an ongoing process that evaluates and selects the safest, most effective, and most economical care for hospitalized patients. As healthcare continues to change, so will the formulary management process.

Pharmacy's Changing Role as Cancer Care Transitions From Infused to Oral Therapies

October 13, 2017

Evidence-Based Oncology

The advent of oral oncolytics has changed the pharmacy's role in patient care beyond compounding infusions. Pharmacy staff now routinely engage patients, assessing adherence and tolerance to therapy as well as helping them navigate prescription benefits.

In Conversation With a Pharmacist: Management of CAR T-Cell Treatment

October 13, 2017

Evidence-Based Oncology

Evidence-Based OncologyTM sat down with Brandon R. Shank, PharmD, MPH, BCOP, clinical pharmacy specialist, Division of Pharmacy, The University of Texas MD Anderson Cancer Center, to understand a pharmacist's role in administering chimeric antigen receptor (CAR) T cells.

AJMC®tv Interviews, October 2017

October 13, 2017

Evidence-Based Oncology

AJMC®TV interviews let you catch up on what’s new and important about changes in healthcare, with insights from key decision makers-from the clinician, to the health plan leader, to the regulator. When every minute in your day matters, AJMC®TV interviews keep you informed. Access the video clips at ajmc.com/interviews.